Zafirlukast
（重定向自Accolate）
![](/Images/godic/202412/19/Zafirlukast.svg0429.png")
![](/Images/godic/202412/19/Zafirlukast_3D_ball-and-stick0429.png")
Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid and/or long-acting bronchodilator. It is available as a tablet and is usually dosed twice daily. Another leukotriene receptor antagonist is montelukast (Singulair), taken once daily. Zileuton (Zyflo), also used in the treatment of asthma via its inhibition of 5-lipoxygenase, is taken four times per day.